Patents by Inventor Ole Graff

Ole Graff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Uses
    Publication number: 20160090421
    Abstract: The present invention relates to the dosing regiment for anti-CD20 antibody to treat various diseases.
    Type: Application
    Filed: October 8, 2015
    Publication date: March 31, 2016
    Inventors: Frederick J. Derosier, Immanuel Freedman, Ole Graff, Richard A. Grove
  • NOVEL METHOD OF USE
    Publication number: 20150202172
    Abstract: The present invention is directed to methods of treating elderly patients with Alitretinoin severe chronic hand eczema (CHE), refractory to treatment with potent topical corticosteroids. One embodiment of the invention is a method of improving the efficacy of Alitretinoin treatment for Severe Refractory Chronic Hand Eczema (CHE) comprising a) identifying and/or selecting a patient in need of treatment, wherein the age of the patient is 50 years old or greater; b) administering an effective amount of Alitretinoin to said patient; c) determining PGA score; and d) discontinuing treatment with Alitretinoin when said patient achieves the PGA score of 1 or 2; thereby. The improvement is also expected to reduce risks in the patient population as continuing treatment will not be necessary.
    Type: Application
    Filed: May 9, 2014
    Publication date: July 23, 2015
    Applicant: Glaxo Group Limited
    Inventors: Ole GRAFF, Susan Marie LEARNED, Virginia SCHMITH, Rajendra SINGH
  • NOVEL USES
    Publication number: 20130315901
    Abstract: A method of treating, arresting or preventing a disease responsive to treatment with an anti-CD20 antibody in a patient suffering therefrom, comprising administering to the patient at least one sub-depleting dose of antiCD20 antibody is disclosed.
    Type: Application
    Filed: January 10, 2012
    Publication date: November 28, 2013
    Applicant: Glaxo Group Limited
    Inventors: Frederick J. Derosier, Immanuel Freedman, Ole Graff, Richard A. Grove
  • Compounds for the sustained reduction of body weight
    Publication number: 20050203124
    Abstract: The invention relates to the use of a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof for a medicament for the for the sustained reduction of body weight.
    Type: Application
    Filed: January 21, 2005
    Publication date: September 15, 2005
    Applicants: Boehringer Ingelheim International GmbH, NeuroSearch A/S
    Inventors: Stephane Pollentier, Andreas Raschig, Juergen Reess, Ole Graff, Birgit Mikkelsen, Morten Priskorn